TITAN PHARMACEUTICALS INC Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Titan Pharmaceuticals Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Titan Pharmaceuticals Inc Debt-to-equity for the quarter ending June 30, 2024 was 17 %, a 93.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 17 -256 -93.8% Jun 30, 2024
Q1 2024 28.8 -74 -72% Mar 31, 2024
Q4 2023 56.9 -0.06 -0.11% Dec 31, 2023
Q3 2023 109 +61.1 +127% Sep 30, 2023
Q2 2023 273 +235 +609% Jun 30, 2023
Q1 2023 103 +67.9 +195% Mar 31, 2023
Q4 2022 56.9 +19.9 +53.9% Dec 31, 2022
Q3 2022 48 +3.28 +7.34% Sep 30, 2022
Q2 2022 38.5 -55.5 -59% Jun 30, 2022
Q1 2022 34.8 -145 -80.6% Mar 31, 2022
Q4 2021 37 -276 -88.2% Dec 31, 2021
Q3 2021 44.7 -406 -90.1% Sep 30, 2021
Q2 2021 94 -481 -83.7% Jun 30, 2021
Q1 2021 180 -722 -80% Mar 31, 2021
Q4 2020 313 -2.21K -87.6% Dec 31, 2020
Q3 2020 450 -14.7 -3.17% Sep 30, 2020
Q2 2020 575 +377 +190% Jun 30, 2020
Q1 2020 902 +703 +354% Mar 31, 2020
Q4 2019 2.53K +2.27K +899% Dec 31, 2019
Q3 2019 465 -167 -26.5% Sep 30, 2019
Q2 2019 198 -855 -81.2% Jun 30, 2019
Q1 2019 199 -15 -7.01% Mar 31, 2019
Q4 2018 253 +161 +176% Dec 31, 2018
Q3 2018 632 +580 +1108% Sep 30, 2018
Q2 2018 1.05K +1.01K +2613% Jun 30, 2018
Q1 2018 214 +172 +409% Mar 31, 2018
Q4 2017 91.6 +37.5 +69.4% Dec 31, 2017
Q3 2017 52.4 -10.9 -17.2% Sep 30, 2017
Q2 2017 38.8 -28.8 -42.6% Jun 30, 2017
Q1 2017 42 -104 -71.2% Mar 31, 2017
Q4 2016 54 -135 -71.5% Dec 31, 2016
Q3 2016 63.2 -138 -68.6% Sep 30, 2016
Q2 2016 67.7 -199 -74.6% Jun 30, 2016
Q1 2016 146 -79.1 -35.1% Mar 31, 2016
Q4 2015 189 -23.4 -11% Dec 31, 2015
Q3 2015 201 -47.8 -19.2% Sep 30, 2015
Q2 2015 266 -76.3 -22.3% Jun 30, 2015
Q1 2015 225 -182 -44.7% Mar 31, 2015
Q4 2014 213 -952 -81.7% Dec 31, 2014
Q3 2014 249 +700 Sep 30, 2014
Q2 2014 343 +591 Jun 30, 2014
Q1 2014 407 +598 Mar 31, 2014
Q4 2013 1.17K +1.32K Dec 31, 2013
Q3 2013 -451 -310 -220% Sep 30, 2013
Q2 2013 -249 -108 -76.6% Jun 30, 2013
Q1 2013 -191 -48.3 -34% Mar 31, 2013
Q4 2012 -155 Dec 31, 2012
Q3 2012 -141 Sep 30, 2012
Q2 2012 -141 Jun 30, 2012
Q1 2012 -142 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.